| Dr Myra Jean Huffman, PHD | |
|
8305 Pine Grove Ct, Louisville, KY 40214-4400 | |
| (502) 937-2587 | |
| (502) 937-8482 |
| Full Name | Dr Myra Jean Huffman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 8305 Pine Grove Ct, Louisville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013095397 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 138101 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Myra Jean Huffman, PHD 8305 Pine Grove Ct, Louisville, KY 40214-4400 Ph: (502) 937-2587 | Dr Myra Jean Huffman, PHD 8305 Pine Grove Ct, Louisville, KY 40214-4400 Ph: (502) 937-2587 |
News Archive
RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage and ingredient supply industries, announced today that it has been notified by the Flavor and Extract Manufacturers Association (FEMA) that its sucrose enhancer, S6973, has been determined to be Generally Recognized As Safe (GRAS) under the provisions of the Federal Food, Drug and Cosmetic Act, administered by the United States Food and Drug Administration (FDA).
As many begin to spend long summer days outside, it's crucial to have the right information about skin protection and the dangers of sun exposure. Today, Montefiore dermatologist Dr. Holly Kanavy debunks many widely-shared myths regarding skin care and offers accurate information to help people enjoy the outdoors this summer while preserving their skin.
A gene involved in some forms of intellectual disability has been identified by scientists at the Centre for Addiction and Mental Health (CAMH), as published this month in The American Journal of Human Genetics. The gene is called TRAPPC9.
Trevena, Inc., a clinical stage biopharmaceutical company and the leader in the discovery of G protein coupled receptor (GPCR) biased ligands, today announced the publication of its Phase 1b data for TRV130 in the journal Pain.
› Verified 7 days ago
Samantha Hii, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Mrs. Lauren Elizabeth Ewing, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Paragon Rehabilitation, Louisville, KY 40299 Phone: 800-335-1060 | |
Laura Kaye Hamdani, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Amy L Scott, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Stephanie Jill Dyer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3920 Dutchmans Ln, Louisville, KY 40207 Phone: 502-259-6608 | |
Kymberly Jean Pennington, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2701 Chestnut Station Ct, Louisville, KY 40299 Phone: 800-335-1060 | |
Joyce M Wooldridge, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1410 Long Run Rd, Louisville, KY 40245 Phone: 502-244-8011 |